93 related articles for article (PubMed ID: 26201290)
1. Melatonin as a preventive and curative therapy against pulmonary hypertension.
Maarman G; Blackhurst D; Thienemann F; Blauwet L; Butrous G; Davies N; Sliwa K; Lecour S
J Pineal Res; 2015 Oct; 59(3):343-53. PubMed ID: 26201290
[TBL] [Abstract][Full Text] [Related]
2. Role of oxidative stress versus lipids in monocrotaline-induced pulmonary hypertension and right heart failure.
Farahmand F; Malik A; Sharma A; Bagchi AK; Singal PK
Physiol Rep; 2021 Nov; 9(22):e15090. PubMed ID: 34816616
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol may prevent the development of congestive hepatopathy secondary to right ventricular hypertrophy associated with pulmonary hypertension in rats.
Krzyżewska A; Baranowska-Kuczko M; Galicka A; Kasacka I; Mińczuk K; Kozłowska H
Pharmacol Rep; 2024 Apr; 76(2):424-434. PubMed ID: 38519732
[TBL] [Abstract][Full Text] [Related]
4. Chronic and moderate consumption of reduced-alcohol wine confers cardiac benefits in a rat model of pulmonary arterial hypertension.
Diaba-Nuhoho P; Cour M; Hadebe N; Marais D; Lecour S; Blackhurst D
BMC Res Notes; 2021 Aug; 14(1):324. PubMed ID: 34425891
[TBL] [Abstract][Full Text] [Related]
5. Beta1-adrenoceptor antagonist, metoprolol attenuates cardiac myocyte Ca
Fowler ED; Drinkhill MJ; Norman R; Pervolaraki E; Stones R; Steer E; Benoist D; Steele DS; Calaghan SC; White E
J Mol Cell Cardiol; 2018 Jul; 120():74-83. PubMed ID: 29807024
[TBL] [Abstract][Full Text] [Related]
6. RV-specific Targeting of Snai1 Rescues Pulmonary Hypertension-induced Right Ventricular Failure by Inhibiting EndMT and Fibrosis
Banerjee S; Onwunyi VRC; Hong J; Martineau S; Fishbein GA; Bonnet SB; Provencher S; Bonnet S; Umar S
bioRxiv; 2024 May; ():. PubMed ID: 38746200
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological approaches in either intermittent or permanent hypoxia: A tale of two exposures.
Herrera EA; Farías JG; Ebensperger G; Reyes RV; Llanos AJ; Castillo RL
Pharmacol Res; 2015 Nov; 101():94-101. PubMed ID: 26215469
[TBL] [Abstract][Full Text] [Related]
8. Novel Strategies in the Treatment of Pulmonary Arterial Hypertension.
Madonna R; Cocco N
Curr Drug Targets; 2016; 17(7):817-23. PubMed ID: 26201488
[TBL] [Abstract][Full Text] [Related]
9. Long-term safety and efficacy of imatinib in pulmonary arterial hypertension.
Frost AE; Barst RJ; Hoeper MM; Chang HJ; Frantz RP; Fukumoto Y; Galié N; Hassoun PM; Klose H; Matsubara H; Morrell NW; Peacock AJ; Pfeifer M; Simonneau G; Tapson VF; Torres F; Dario Vizza C; Lawrence D; Yang W; Felser JM; Quinn DA; Ghofrani HA
J Heart Lung Transplant; 2015 Nov; 34(11):1366-75. PubMed ID: 26210752
[TBL] [Abstract][Full Text] [Related]
10. Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.
Galiè N; Barberà JA; Frost AE; Ghofrani HA; Hoeper MM; McLaughlin VV; Peacock AJ; Simonneau G; Vachiery JL; Grünig E; Oudiz RJ; Vonk-Noordegraaf A; White RJ; Blair C; Gillies H; Miller KL; Harris JH; Langley J; Rubin LJ;
N Engl J Med; 2015 Aug; 373(9):834-44. PubMed ID: 26308684
[TBL] [Abstract][Full Text] [Related]
11. Targeted activation of endothelin-1 exacerbates hypoxia-induced pulmonary hypertension.
Satwiko MG; Ikeda K; Nakayama K; Yagi K; Hocher B; Hirata K; Emoto N
Biochem Biophys Res Commun; 2015 Sep; 465(3):356-62. PubMed ID: 26275708
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm.
Frantz RP
Eur Respir J; 2015 Aug; 46(2):299-302. PubMed ID: 26232475
[No Abstract] [Full Text] [Related]
13. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial.
Ehlken N; Lichtblau M; Klose H; Weidenhammer J; Fischer C; Nechwatal R; Uiker S; Halank M; Olsson K; Seeger W; Gall H; Rosenkranz S; Wilkens H; Mertens D; Seyfarth HJ; Opitz C; Ulrich S; Egenlauf B; Grünig E
Eur Heart J; 2016 Jan; 37(1):35-44. PubMed ID: 26231884
[TBL] [Abstract][Full Text] [Related]
14. Saudi experience in the management of pulmonary arterial hypertension; the outcome of PAH therapy with the exclusion of chronic parenteral prostacyclin.
Idrees M; Alnajashi K; Abdulhameed J; Khan A; Batubara E; Alotay A; Fayed A; Aldammas S; Alseif M; Alawwad H; Abusabaa Y; Almobrad M; Kashour T;
Ann Thorac Med; 2015; 10(3):204-11. PubMed ID: 26229564
[TBL] [Abstract][Full Text] [Related]
15. The molecular targets of approved treatments for pulmonary arterial hypertension.
Humbert M; Ghofrani HA
Thorax; 2016 Jan; 71(1):73-83. PubMed ID: 26219978
[TBL] [Abstract][Full Text] [Related]
16. Melatonin in Heart Failure: A Promising Therapeutic Strategy?
Nduhirabandi F; Maarman GJ
Molecules; 2018 Jul; 23(7):. PubMed ID: 30037127
[TBL] [Abstract][Full Text] [Related]
17. New pharmacotherapy options for pulmonary arterial hypertension.
Perrin S; Chaumais MC; O'Connell C; Amar D; Savale L; Jaïs X; Montani D; Humbert M; Simonneau G; Sitbon O
Expert Opin Pharmacother; 2015; 16(14):2113-31. PubMed ID: 26290279
[TBL] [Abstract][Full Text] [Related]
18. Severe pulmonary hypertension associated with COPD: hemodynamic improvement with specific therapy.
Girard A; Jouneau S; Chabanne C; Khouatra C; Lannes M; Traclet J; Turquier S; Delaval P; Cordier JF; Cottin V
Respiration; 2015; 90(3):220-8. PubMed ID: 26277885
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Cell Cycle Regulators by SIRT1 Contributes to Resveratrol-Mediated Prevention of Pulmonary Arterial Hypertension.
Zhou S; Li MT; Jia YY; Liu JJ; Wang Q; Tian Z; Liu YT; Chen HZ; Liu DP; Zeng XF
Biomed Res Int; 2015; 2015():762349. PubMed ID: 26273643
[TBL] [Abstract][Full Text] [Related]
20. Mechanical Support for the Failing Right Ventricle in Patients With Precapillary Pulmonary Hypertension.
Machuca TN; de Perrot M
Circulation; 2015 Aug; 132(6):526-36. PubMed ID: 26260498
[No Abstract] [Full Text] [Related]
[Next] [New Search]
